Hironic
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Hironic makes medical devices that use focused energy, including high-intensity focused ultrasound (HIFU), radiofrequency, and laser technologies, to tighten skin, reduce wrinkles, and reshape body contours without surgery.
Its devices are used by clinics and hospitals, and the company is also developing versions for personal home use. Listed on KOSDAQ, Korea's tech-focused small-cap exchange, Hironic pursues both the professional medical-clinic market and the consumer home-care device market simultaneously.
Summary is AI-generated and may contain errors · figures from DART filings
Hironic in five facts
What does Hironic do?
Hironic makes medical devices that use focused energy, including high-intensity focused ultrasound (HIFU), radiofrequency, and laser technologies, to tighten skin, reduce wrinkles, and reshape body contours without surgery.
Where is Hironic listed and in which sector?
Hironic (Korean name: 하이로닉) trades under KRX code 149980 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Hironic?
Its market capitalisation was US$53.1M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Hironic's latest annual revenue and operating profit?
For fiscal year 2025, Hironic reported revenue of US$24.2M, operating profit of US$3.1M and net income of US$2.4M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 1.4% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Cash/in-kind dividend decision
Hironic declared a cash dividend of US$0.16 per share, equal to about 4.94% of the recent share price.
Dividend · Jul 16 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Hironic reported consolidated results for FY2025: revenue of US$21.8M (−4.8% year on year), operating profit of US$2.8M (−21.9% year on year) and net income of US$2.02M (−64% year on year).
Earnings · Mar 13 - Securities issuance results (voluntary) (third-party placement)Capital raise · Jan 22